Related Experiment Video
Updated: Jun 18, 2026

Analyzing Mitochondrial Function in a Drosophila melanogaster PINK1B9-Null Mutant Using High-resolution Respirometry
Published on: November 10, 2023
Proproliferative functions of Drosophila small mitochondrial heat shock protein 22 in human cells
Renu Wadhwa1, Jihoon Ryu2, Ran Gao1
1From the National Institute of Advanced Industrial Science and Technology, Central 4, 1-1-1 Higashi, Tsukuba, Ibaraki 305 8562, Japan.
Abstract:
Aging is a complex process accompanied by a decreased capacity of cells to cope with random damages induced by reactive oxygen species, the natural by-products of energy metabolism, leading to protein aggregation in various components of the cell. Chaperones are important players in the aging process as they prevent protein misfolding and aggregation. Small chaperones, such as small heat shock proteins, are involved in the refolding and/or disposal of protein aggregates, a feature of many age-associated diseases. In Drosophila melanogaster, mitochondrial Hsp22 (DmHsp22), is localized in the mitochondrial matrix and is preferentially up-regulated during aging. Its overexpression results in an extension of life span (>30%) (Morrow, G., Samson, M., Michaud, S., and Tanguay, R. M. (2004) FASEB J. 18, 598-599 and Morrow, G., Battistini, S., Zhang, P., and Tanguay, R. M. (2004) J. Biol. Chem. 279, 43382-43385). Long lived flies expressing Hsp22 also have an increased resistance to oxidative stress and maintain locomotor activity longer. In the present study, the cross-species effects of Hsp22 expression were tested. DmHsp22 was found to be functionally active in human cells. It extended the life span of normal fibroblasts, slowing the aging process as evidenced by a lower level of the senescence associated beta-galactosidase. DmHsp22 expression in human cancer cells increased their malignant properties including anchorage-independent growth, tumor formation in nude mice, and resistance to a variety of anticancer drugs. We report that the DmHsp22 interacts and inactivates wild type tumor suppressor protein p53, which may be one possible way of its functioning in human cells.
Insights
Mitochondrial Hsp22 protein slows aging in human cells and extends lifespan. However, it also enhances cancer cell malignancy and drug resistance by inactivating the p53 tumor suppressor protein.
Area of Science:
- Cellular biology
- Aging research
- Molecular biology
Background:
- Aging involves cellular damage and protein aggregation.
- Chaperones, like small heat shock proteins, combat misfolding and aggregation.
- Mitochondrial Hsp22 (DmHsp22) in Drosophila melanogaster is upregulated during aging and extends lifespan.
Purpose of the Study:
- To investigate the cross-species effects of DmHsp22.
- To determine if DmHsp22 can slow aging in human cells.
- To assess the impact of DmHsp22 on human cancer cells.
Main Methods:
- Expressing DmHsp22 in normal human fibroblasts and human cancer cells.
- Measuring senescence-associated beta-galactosidase levels.
- Evaluating cancer cell malignancy (anchorage-independent growth, tumor formation in mice).
- Assessing drug resistance.
- Investigating interaction with p53 tumor suppressor protein.
Main Results:
- DmHsp22 is functionally active in human cells.
- DmHsp22 extended the lifespan of normal fibroblasts, reducing senescence.
- DmHsp22 increased malignancy and drug resistance in cancer cells.
- DmHsp22 was found to interact with and inactivate wild-type p53.
Conclusions:
- DmHsp22 can slow the aging process in human cells.
- DmHsp22 enhances malignant properties of human cancer cells, potentially via p53 inactivation.
- DmHsp22 has conserved functions across species, impacting both aging and cancer biology.
Related Concept Videos
Abnormal Proliferation
Replicative Cell Senescence
Mitogens and the Cell Cycle
Energy to Drive Translocation
Generally, polypeptides are unfolded by two distinct...
Mitochondria
DNA Damage can Stall the Cell Cycle

